Guest Edited by: Orazio Fortunato, Irina Matei and Chunlin Ou
Collection Open for Submissions
Schulz et al. characterized two human GBM models (U87-luc2, U251-RedFLuc) in vitro and in vivo, showing that they recapitulate different aspects of GBM heterogeneity that need to be considered in preclinical research.
Fragoso Costa et al. determined the lowest 18F-FDG PET acquisition time without loss of diagnostic information and optimised image reconstruction parameters by phantom imaging.
Montagna et al. investigated the hyperprogressive-cancer disease in two murine tumors widely different regarding immunogenicity and in models of local recurrences and metastases.
Click here to view which Articles have been shared most in the last month!
Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions
Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions
Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020
Cross journal collection: Precision Oncology
Collection published: 28 August 2019
Learn more about study protocols at BMC Cancer here
Aims and Scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here.
September - Childhood Cancer Awareness Month
Childhood Cancer awareness month runs for the whole of September. While childhood cancer is rare, it is the leading cause of disease-related death past infancy in children and adolescents. Survival rates for most childhood cancers have improved in recent decades, however many children will have long-term side-effects that may significantly impact their lives forever. In the paper below Masumoto et al. reported game-based learning programs as tools that can be effectively applied to survivorship care as a new modality of patient education.
Join our Editorial Board
Interested in joining the editorial board of BMC Cancer?
More information and how to apply can be found here. We are looking forward to hearing from you.
Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades.
BMC Series Blog
Annual Journal Metrics
37 days to first decision for all manuscripts (Median)
65 days to first decision for reviewed manuscripts only (Median)
6,897,358 Downloads (2021)
4,517 Altmetric mentions (2021)
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication